Skip Navigation
Skip to contents



10 results

Determination of normative reference for the definition of sarcopenia among Filipinos

Tee ML, Tee CA, Montemayor EB

  • Osteoporos Sarcopenia.
  • 2016 Sep;2(3):186-190.
  • doi: 10.1016/j.afos.2016.07.004
BACKGROUND: At present, there is no normative value that can be used in the definition of sarcopenia in the Philippines. OBJECTIVE: We identified the reference cut-off values for: 1) muscle mass...
The cause of failure to return to the pre-fracture place of residence and solution to continue medical treatment for osteoporosis following an operation for hip fracture - Periodic observation of single center

Tanaka M, Itoh S, Kato Y

  • Osteoporos Sarcopenia.
  • 2016 Sep;2(3):180-185.
  • doi: 10.1016/j.afos.2016.06.004
The purpose of this study was to investigate the causes of failure to return to the pre-fracture place of residence at hospital discharge following an operation for a hip fracture...
Changes in bone mineral density and trabecular bone score in Graves' disease patients after anti-thyroid therapy

Ock SY, Chung YS, Choi YJ

  • Osteoporos Sarcopenia.
  • 2016 Sep;2(3):175-179.
  • doi: 10.1016/j.afos.2016.05.004
OBJECTIVE: The purpose of this study was to evaluate changes in bone quantity based on bone mineral density (BMD) and bone quality based on trabecular bone score (TBS) in Graves'...
Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate

Kamimura M, Nakamura Y, Ikegami S, Komatsu M, Uchiyama S, Kato H

  • Osteoporos Sarcopenia.
  • 2016 Sep;2(3):170-174.
  • doi: 10.1016/j.afos.2016.07.002
As a bisphosphonate, minodronate (MIN) is one of the strongest inhibitors of bone resorption. However, there have been no reports directly comparing the antiresorptive effects of monthly MIN with those...
The effects of spinal cord injury on bone loss and dysregulation of the calcium/parathyroid hormone loop in mice

Rivero TD, Bethea JR

  • Osteoporos Sarcopenia.
  • 2016 Sep;2(3):164-169.
  • doi: 10.1016/j.afos.2016.06.003
OBJECTIVE: To map the progression of osteoporosis following spinal cord injury in mice in specific areas and analyze changes in parathyroid hormone (PTH) and ion levels which could be responsible...
Locomotive syndrome presents a risk for falls and fractures in the elderly Japanese population

Matsumoto , Hagino H, Wada T, Kobayashi

  • Osteoporos Sarcopenia.
  • 2016 Sep;2(3):156-163.
  • doi: 10.1016/j.afos.2016.06.001
"Locomotive syndrome" is used to designate the condition of individuals with musculoskeletal disease who are highly likely to require nursing care. This article reviews screening, prevalence, causal and related factors,...
The role of sex steroid hormones in the pathophysiology and treatment of sarcopenia

Kim YJ, Tamadon A, Park HT, Kim H, Ku SY

  • Osteoporos Sarcopenia.
  • 2016 Sep;2(3):140-155.
  • doi: 10.1016/j.afos.2016.06.002
Sex steroids influence the maintenance and growth of muscles. Decline in androgens, estrogens and progesterone by aging leads to the loss of muscular function and mass, sarcopenia. These steroid hormones...
A practical approach to secondary osteoporosis - Case studies in Asia

Lim V

  • Osteoporos Sarcopenia.
  • 2016 Sep;2(3):134-139.
  • doi: 10.1016/j.afos.2016.07.003
Osteoporosis is a major health disease that is increasing in Asia especially given the rapidly aging population in many of the countries. A major aim of the management of osteoporosis...
Osteoporosis in East Asia: Current issues in assessment and management

Cheung EY, Tan KC, Cheung CL, Kung AW

  • Osteoporos Sarcopenia.
  • 2016 Sep;2(3):118-133.
  • doi: 10.1016/j.afos.2016.07.001
The greatest burden of hip fractures around the world is expected to occur in East Asia, especially China. However, there is a relative paucity of information on the epidemiology and...
Encouraging appropriate osteoporosis medication to prevent fracture

Tsai KS

  • Osteoporos Sarcopenia.
  • 2016 Sep;2(3):117-117.
  • doi: 10.1016/j.afos.2016.07.005
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: